TipRanks
Advertisement
Advertisement

DE:ZA8 Stock Latest News

Zymeworks price target raised to $34 from $32 at Truist
The FlyZymeworks price target raised to $34 from $32 at Truist
3d ago
ZYME
Zymeworks reinstated with a Buy at TD Cowen
PremiumThe Fly
Zymeworks reinstated with a Buy at TD Cowen
11d ago
ZYME
Zymeworks price target raised to $39 from $38 at Citi
PremiumThe Fly
Zymeworks price target raised to $39 from $38 at Citi
11d ago
ZYME
LifeSci flags Yupelri as a key growth driver after Zymeworks’ Theravance deal
PremiumThe Fly
LifeSci flags Yupelri as a key growth driver after Zymeworks’ Theravance deal
12d ago
ZYME
Charles Zhu Reiterates Buy on Zymeworks, Keeps $34 Price Target After TBPH Acquisition Boosts Growth and Cash Flow Outlook
PremiumRatings
Charles Zhu Reiterates Buy on Zymeworks, Keeps $34 Price Target After TBPH Acquisition Boosts Growth and Cash Flow Outlook
12d ago
ZYME
Midday Fly By: Nvidia boosts buyback, Boeing discovers 737 Max glitch
PremiumThe FlyMidday Fly By: Nvidia boosts buyback, Boeing discovers 737 Max glitch
12d ago
BA
NU
Zymeworks sees FY26 revenue $278M-$292M, consensus $304.04M
Premium
The Fly
Zymeworks sees FY26 revenue $278M-$292M, consensus $304.04M
12d ago
ZYME
Zymeworks announces financial impact of Theravance Biopharma acquisition
Premium
The Fly
Zymeworks announces financial impact of Theravance Biopharma acquisition
12d ago
ZYME
Zymeworks Closes Theravance Acquisition and CVR Financing
PremiumCompany Announcements
Zymeworks Closes Theravance Acquisition and CVR Financing
16d ago
8K
ZYME
Zymeworks initiated with an Outperform at Wolfe Research
PremiumThe Fly
Zymeworks initiated with an Outperform at Wolfe Research
23d ago
ZYME
Zymeworks price target raised to $33 from $31 at JPMorgan
PremiumThe Fly
Zymeworks price target raised to $33 from $31 at JPMorgan
1M ago
ZYME
Zymeworks price target raised to $38 from $37 at Citi
PremiumThe Fly
Zymeworks price target raised to $38 from $37 at Citi
1M ago
ZYME
Zymeworks price target raised to $55 from $51 at H.C. Wainwright
PremiumThe FlyZymeworks price target raised to $55 from $51 at H.C. Wainwright
1M ago
ZYME
Zymeworks Gains $250 Million Milestone as Jazz Wins FDA Nod for HER2 Cancer Regimens
Premium
Company Announcements
Zymeworks Gains $250 Million Milestone as Jazz Wins FDA Nod for HER2 Cancer Regimens
2M ago
ZYME
Zymeworks Gains Second FDA Nod for Zanidatamab, Unlocking Major Milestones
Premium
Company Announcements
Zymeworks Gains Second FDA Nod for Zanidatamab, Unlocking Major Milestones
2M ago
ZYME
BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA
PremiumThe Fly
BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA
2M ago
ONC
JAZZ
Zymeworks says partner Jazz receives FDA approval for Ziihera regimens
PremiumThe Fly
Zymeworks says partner Jazz receives FDA approval for Ziihera regimens
2M ago
ONC
JAZZ
Zymeworks Steps Up Investor Outreach with September Conference Lineup
PremiumCompany Announcements
Zymeworks Steps Up Investor Outreach with September Conference Lineup
2M ago
ZYME
Zymeworks price target raised to $44 from $40 at B. Riley
PremiumThe Fly
Zymeworks price target raised to $44 from $40 at B. Riley
2M ago
ZYME
Citi adds ‘upside 90-day catalyst watch’ on Zymeworks in FDA decision
PremiumThe FlyCiti adds ‘upside 90-day catalyst watch’ on Zymeworks in FDA decision
2M ago
ZYME
Zymeworks price target raised to $32 from $31 at Truist
Premium
The Fly
Zymeworks price target raised to $32 from $31 at Truist
2M ago
ZYME
Zymeworks price target lowered to $46 from $47 at Stifel
Premium
The Fly
Zymeworks price target lowered to $46 from $47 at Stifel
2M ago
ZYME

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >